Double-blind, placebo-controlled phase IIb French trial of BTI 320 [PAZ 320] in patients with type 2 diabetes mellitus who are being treated with metformin
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2014
Price : $35 *
At a glance
- Drugs BTI 320 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Boston Therapeutics
- 09 Oct 2014 Study stated to be ongoing, according to a Boston Therapeutics media release.
- 12 Nov 2013 Status changed from planning to recruiting. Patient enrolment has begun, according to a Boston Therapeutics media release.
- 14 Sep 2013 New trial record